adenosine
NDC 67457-855, adenosine, injection, from Mylan Institutional LLC.
- Product NDC
- 67457-855
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078686
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-855 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADENOSINE3 mg/mL
Pharmacologic classes
Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-855-02 | 67457085502 | 10 VIAL, SINGLE-DOSE in 1 CARTON (67457-855-02) / 2 mL in 1 VIAL, SINGLE-DOSE (67457-855-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d2d06ee6-c89f-49f7-9e2c-46d33ce877a9Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67457-855
Use it
Look up 67457-855 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-855 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-855. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.